Puvasoralen (8-methoxysoralen)
/ York Pharmaceuticals
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 14, 2024
IRON DEFICIENCY IN PATIENTS UNDERGOING EXTRACORPOREAL PHOTOPHERESIS (ECP)
(EBMT 2024)
- "Secondly, a photosensitizing drug called 8- methoxypsoralen (UVADEXTM) is injected to the collected mononuclear cells. Iron deficiency can occur with ECP treatment. Therefore, this risk factor should be monitored. Moosavi et al."
Clinical • Acute Graft versus Host Disease • Anemia • Bone Marrow Transplantation • Chronic Graft versus Host Disease • Graft versus Host Disease • Hematological Disorders • Immunology • Transplantation
1 to 1
Of
1
Go to page
1